{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:56:42Z","timestamp":1792789002288,"version":"4.5.0"},"reference-count":23,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:00:00Z","timestamp":1760227200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Innovate Biopharmaceuticals Inc."}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Background\/Objective: Larazotide acetate (LA) is a synthetic octapeptide under development as a therapeutic candidate for celiac disease, acting to reduce intestinal permeability and regulate tight junctions (TJs). Although several studies have shown barrier-protective effects, the cellular mechanisms underlying LA\u2019s actions in the intestinal epithelium remain unclear. This study aimed to elucidate the mechanistic roles of LA in maintaining intestinal epithelial integrity during cellular injury. Methods: C2BBe1 and leaky IPEC-J2 cell monolayers were pretreated with 10 mM LA and subjected to anoxia\/reoxygenation (A\/R) injury. Transepithelial electrical resistance (TEER), TJ protein localization, and phosphorylation of myosin light chain-2 (MLC-2) were analyzed. In addition, RNA sequencing was conducted to identify differentially expressed genes and signaling pathways affected by LA treatment. Results: LA pretreatment significantly increased TEER and preserved TJ protein organization during A\/R injury. Transcriptomic analysis revealed enrichment of genes related to barrier regulation, small GTPase signaling, protein phosphorylation, proliferation, and migration. LA pretreatment markedly reduced MLC-2 phosphorylation, likely through modulation of the ROCK pathway, consistent with RNA-seq findings. Moreover, LA enhanced cellular proliferation, validating transcriptomic predictions. Conclusions: LA exerts a protective effect on intestinal epithelial integrity by stabilizing tight junctions, reducing MLC-2 phosphorylation, and promoting epithelial proliferation. These findings highlight a novel mechanism for LA and support its therapeutic potential in treating gastrointestinal disorders associated with \u201cleaky gut\u201d and mucosal injury.<\/jats:p>","DOI":"10.3390\/biomedicines13102483","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T05:48:21Z","timestamp":1760420901000},"page":"2483","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Larazotide Acetate Protects the Intestinal Mucosal Barrier from Anoxia\/Reoxygenation Injury via Various Cellular Mechanisms"],"prefix":"10.3390","volume":"13","author":[{"given":"Jain","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"Madan","sequence":"additional","affiliation":[{"name":"Innovate Biopharmaceuticals Inc., Raleigh, NC 27615, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Laumas","sequence":"additional","affiliation":[{"name":"Innovate Biopharmaceuticals Inc., Raleigh, NC 27615, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Radha","family":"Krishnan","sequence":"additional","affiliation":[{"name":"Innovate Biopharmaceuticals Inc., Raleigh, NC 27615, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2450-9330","authenticated-orcid":false,"given":"Younggeon","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Animal and Avian Sciences, University of Maryland, College Park, MD 20742, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1105906","DOI":"10.1080\/21688370.2015.1105906","article-title":"ClC-2 regulation of intestinal barrier function: Translation of basic science to therapeutic target","volume":"3","author":"Jin","year":"2015","journal-title":"Tissue Barriers"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ayansola, H., Mayorga, E.J., and Jin, Y. (2024). Subepithelial Stromal Cells: Their Roles and Interactions with Intestinal Epithelial Cells during Gut Mucosal Homeostasis and Regeneration. Biomedicines, 12.","DOI":"10.20944\/preprints202402.0346.v1"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"G647","DOI":"10.1152\/ajpgi.00183.2006","article-title":"Recovery of mucosal barrier function in ischemic porcine ileum and colon is stimulated by a novel agonist of the ClC-2 chloride channel, lubiprostone","volume":"292","author":"Moeser","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"C423","DOI":"10.1152\/ajpcell.00348.2015","article-title":"Beyond Ussing\u2019s chambers: Contemporary thoughts on integration of transepithelial transport","volume":"310","author":"Herrmann","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Jin, Y., and Blikslager, A.T. (2020). The Regulation of Intestinal Mucosal Barrier by Myosin Light Chain Kinase\/Rho Kinases. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21103550"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00428-012-1195-1","article-title":"Comparative tight junction protein expressions in colonic Crohn\u2019s disease, ulcerative colitis, and tuberculosis: A new perspective","volume":"460","author":"Das","year":"2012","journal-title":"Virchows Arch."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/MPG.0000000000000338","article-title":"Alteration of tight junction gene expression in celiac disease","volume":"58","author":"Irastorza","year":"2014","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jcmgh.2017.09.005","article-title":"Hypoxia in the Gut","volume":"5","author":"Taylor","year":"2017","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"C996","DOI":"10.1152\/ajpcell.00113.2016","article-title":"Myosin light chain kinase mediates intestinal barrier dysfunction via occludin endocytosis during anoxia\/reoxygenation injury","volume":"311","author":"Jin","year":"2016","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijpharm.2008.08.047","article-title":"Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer","volume":"365","author":"Gopalakrishnan","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.peptides.2012.02.015","article-title":"Larazotide acetate regulates epithelial tight junctions in vitro and in vivo","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.peptides.2012.02.016","article-title":"Larazotide acetate promotes tight junction assembly in epithelial cells","volume":"35","author":"Gopalakrishnan","year":"2012","journal-title":"Peptides"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1136\/gutjnl-2020-323026","article-title":"Blurring the picture in leaky gut research: How shortcomings of zonulin as a biomarker mislead the field of intestinal permeability","volume":"9","author":"Massier","year":"2021","journal-title":"Gut"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1136\/gutjnl-2020-323829","article-title":"Lack of relationship of AT1001 to zonulin and prehaptoglobin-2: Clinical implications","volume":"70","author":"Sollid","year":"2021","journal-title":"Gut"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Slifer, Z.M., Hernandez, L., Pridgen, T.A., Carlson, A.R., Messenger, K.M., Madan, J., Krishnan, B.R., Laumas, S., and Blikslager, A.T. (2021). Larazotide acetate induces recovery of ischemia-injured porcine jejunum via repair of tight junctions. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0250165"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1073\/pnas.0500178102","article-title":"Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats","volume":"102","author":"Watts","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1242\/jcs.113.24.4435","article-title":"Human zonulin, a potential modulator of intestinal tight junctions","volume":"113","author":"Wang","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Scheffler, L., Crane, A., Heyne, H., Tonjes, A., Schleinitz, D., Ihling, C.H., Stumvoll, M., Freire, R., Fiorentino, M., and Fasano, A. (2018). Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Front. Endocrinol., 9.","DOI":"10.3389\/fendo.2018.00022"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/gut.2008.150888","article-title":"Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse","volume":"58","author":"Arrieta","year":"2009","journal-title":"Gut"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2036.2007.03413.x","article-title":"The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: A proof of concept study","volume":"26","author":"Paterson","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/apt.12147","article-title":"Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: A randomised placebo-controlled study","volume":"37","author":"Kelly","year":"2013","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MIB.0000000000000184","article-title":"Necrotizing enterocolitis: A clinical review on diagnostic biomarkers and the role of the intestinal microbiota","volume":"21","author":"Niemarkt","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/MPG.0b013e3182a7dc74","article-title":"Pathogenesis implication for necrotizing enterocolitis prevention in preterm very-low-birth-weight infants","volume":"58","author":"Chen","year":"2014","journal-title":"J. Pediatr. Gastroenterol. Nutr."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:23:07Z","timestamp":1760422987000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/13\/10\/2483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,12]]},"references-count":23,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["biomedicines13102483"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines13102483","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,12]]}}}